Steroids often prescribed for psoriasis, countering guidelines

March 3, 2014
Binge drinking may double older people's risk of dying

(HealthDay News)—Although corticosteroid pills are not recommended for the management of psoriasis, new research reveals these drugs are commonly prescribed by dermatologists treating this chronic skin condition.

Corticosteroids, including prednisone, dexamethasone and methylprednisolone, were the second most commonly prescribed systemic medications (not preparations applied to the skin) for , according to a study from Wake Forest Baptist Medical Center.

"Expert guidelines discourage their use for psoriasis due to concerns about causing flares of generalized pustular psoriasis, but there are no of systemic in psoriasis to look at these issues," study co-author Scott Davis, assistant director of the Center for Dermatology Research at Wake Forest Baptist Medical Center, said in a Wake Forest news release.

In conducting the study, recently published online in the Journal of Cutaneous Medicine and Surgery, the researchers examined survey data collected on systemic medications used to treat psoriasis from 1989 to 2010.

Out of 21 million office visits, corticosteroids were prescribed 650,000 times. The study's authors noted the vast majority, or 93 percent, of these prescriptions were written by dermatologists.

"Psoriasis has an enormous impact on patients' lives, and there have been major recent advances in treatment," Davis noted. "While the new treatments are highly effective and appear very safe, they are costly; their effects are well studied. In contrast, while corticosteroids have been available for decades, their use in psoriasis has not been extensively studied."

Explore further: Skin care tips for psoriasis patients

Related Stories

Skin care tips for psoriasis patients

August 25, 2013
(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an ...

Evaluation of pediatric psoriasis outpatient health care delivery finds some treatment variability

September 19, 2011
Most outpatient visits for pediatric psoriasis in the United States are made by white children ages 8 years and older and are made to dermatologists and pediatricians, but the treatment approach may differ by physician specialty ...

Largest clinical trial for potential new psoriasis treatment

December 10, 2013
Novartis Pharmaceuticals UK has announced the launch of the UK's largest clinical trial to investigate a potential new biologic treatment for adults with moderate-severe psoriasis.

Many psoriasis patients going without treatment, study finds

August 15, 2013
(HealthDay)—The autoimmune skin disorder known as psoriasis affects millions of Americans, but a new study suggests it remains woefully undertreated.

Psoriasis tied to increased risk of new-onset diabetes

March 27, 2013
(HealthDay)—Psoriasis is significantly tied to an increased risk of new-onset diabetes mellitus (DM), according to a study published online March 14 in Diabetes Care.

UVB preferred for treatment of moderate to severe psoriasis

February 24, 2012
(HealthDay) -- Ultraviolet B (UVB) is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March issue of the ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.